Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Typesort ascending Project # RFA # PI/Project Leader Institution Title Status
2020 R44 PAR-18-303 WINTERS, IAN PAUL D2G ONCOLOGY, INC. Relating Drugs To Genotypes To Transform Precision Cancer Therapeutics With Tuba-seq - A Novel, Highly Scalable And Quantitative Preclinical Experimental Oncology Platform Active
2005 R44 RFA-CA-05-006 RUSH, JOHN CELL SIGNALING TECHNOLOGY, INC. IMMUNOAFFINITY ISOLATION OF PHOSPHOPEPTIDES Complete
2005 R44 PAR-01-105 BALGLEY, BRIAN M. CALIBRANT BIOSYSTEMS, INC. INTEGRATED TOP-DOWN/BOTTOM-UP COMPREHENSIVE PROTEOMICS Complete
2008 R44 RFA-CA-07-039 GUO, BAOCHUAN GLC BIOTECHNOLOGY, INC. MMPA: A NOVEL MULTIPLEXING METHYLATION ANALYSIS TECHNOLOGY Complete
2008 R44 RFA-CA-07-041 LEE, BRIAN W IMMUNOCHEMISTRY TECHNOLOGIES, LLC NEW FLUORESCENT CASPASE DETECTION PROBES TO LABEL APOPTOTIC TUMOR CELLS IN VIVO Complete
2006 R44 RFA-CA-06-006 BROWN, DAVID M AMBION DIAGNOSTICS, INC. MIRNA PROFILING IN FIXED CANCER SAMPLES Complete
2008 R44 RFA-CA-07-039 LIM, MARK AMBERGEN, INC ADVANCED TECHNOLOGY FOR ASSAYING CANCER-DRUG RESISTANCE Complete
2006 R44 RFA-CA-06-005 BRADY, ERIK D MICROCOSM, INC. ENHANCED CANCER MICROARRAY Complete
2020 R43 PAR-18-303 ERVIN, ERIC ELECTRONIC BIOSCIENCES, INC. N6-Methyl-2-O-Methyladenosine Sequencing Active
2002 R43 PAR-01-105 MARTIN, MARK MIRARI BIOSCIENCES, INC. MICROWAVE-ENHANCED LUMINESCENCE TO DETECT GROWTH FACTORS Complete
2015 R43 PAR-13-327 ORBAI, LUCIAN CELL DATA SCIENCES, INC. RESCUING NUCLEIC ACIDS FROM FORMALIN DAMAGE IN CANCER SPECIMENS Complete
1999 R43 PAR-98-066 CHANG, HWAI W STRATAGENE GENETIC SELECTION FOR PROTEASES AND THEIR SUBSTRATES Complete
2001 R43 PAR-99-101 KOGON, ALEX A BIOLINX, LLC SELECTION OF THE BEST LIGANDS FROM COMBINATORIAL LIBRARY Complete
2016 R43 PAR-13-327 OUELLETTE, STEVEN BRADLEY KINASENSE, LLC DEVELOPMENT OF AN ASSAY PLATFORM FOR MEASURING ENDOGENOUS KINASE ACTIVITY Complete
2016 R43 PAR-13-327 KLUGE, JONATHAN AUGUST VAXESS TECHNOLOGIES, INC. SILK-BASED BLOOD SAMPLE STABILIZATION FOR PROSTATE CANCER DIAGNOSTICS Complete
2002 R43 PAR-01-105 FENG, LI ECHELON BIOSCIENCES, INC. LIPID MICROARRAYS Complete
2015 R43 PAR-13-327 EASTBURN, DENNIS J MISSION BIO, INC. MOLECULAR CHARACTERIZATION OF CIRCULATING TUMOR CELLS WITH PCR-ACTIVATED CELL SORTING Complete
1999 R43 PAR-98-066 MILLER, JEFFREY E. IVS TECHNOLOGIES, LLC NEW METHOD FOR THE SYNTHESIS OF CDNA FROM CANCER CELLS Complete
2001 R43 PAR-99-101 SHEN, SHANXIANG PROTIVERIS, INC. MICROCANTILEVER ARRAY DEVICE FOR PROTEIN PROFILING Complete
2016 R43 PAR-13-327 GUNDERSON, KEVIN L ENCODIA, INC. Development of Reagents for Sequencing Proteins and Protein Fragments on a Next-Generation DNA Sequencer Complete
2020 R43 PAR-18-303 WANG, SHA VIVID TECHNOLOGIES New specific and rapid assay for in situ apoptosis labeling for cancer studies Active
2002 R43 PAR-01-105 ISRAEL, BARBARA A. PLATYPUS TECHNOLOGIES, LLC OBLIQUELY DEPOSITED SUBSTRATES FOR DETECTION OF RAS Complete
2015 R43 PAR-13-327 GAU, VINCENT JEN-JR GENEFLUIDICS, INC. PROMOTE HPV SCREENING RATE WITH A NON-INVASIVE HPV POC CARTRIDGE Complete
1999 R43 PAR-98-066 NERI, BRUCE P THIRD WAVE TECHNOLOGIES, INC. SPECIFIC AND SENSITIVE MUTATION AND SNP DETECTION Complete
2001 R43 PAR-99-101 WANG, PENCHENG CALIBRANT BIOSYSTEMS, INC. 2-D MICROFLUIDIC GENE SCANNER Complete
2004 R43 PAR-01-105 BECKER, CHRISTOPHER H SURROMED, INC. DIFFERENTIAL EXPRESSION MEASUREMENTS OF PHOSPHOPROTEOME Complete
2016 R43 PAR-13-327 LIM, MARK AMBERGEN, INC Photocleavage Technology for Improved Serum-based Multi-Biomarker Cancer Assays Complete
2002 R43 PAR-01-105 BECKER, CHRISTOPHER SURROMED, INC. AFFINITY MASS TAGS FOR DIFFERENTIAL PHENOTYPING Complete
1999 R43 PAR-98-066 WEAVER, DANIEL C GENOMICA CORPORATION ANALYZING GENE EXPRESSION FOR CANCER GENE DISCOVERY Complete
2001 R43 PAR-99-101 WANG, JIWU ALLELE BIOTECHNOLOGY AND PHARMACEUTICALS INNOVATIVE RNA PROFILING IN CANCER CELLS Complete
2004 R43 PAR-01-105 NIELSEN, ULRIK B. MERRIMACK PHARMACEUTICALS, INC. PRODUCTION OF ANTIBODIES SUITABLE FOR MICROARRAYS Complete
2016 R43 PAR-13-327 KING, JEFFREY S VIROGENOMICS BIODEVELOPMENT, INC. Sensitive Single Cell PhosphoCount Platform for Drug-Insensitive Cell Detection and Combination Drug Screening for Leukemia Complete
2000 R43 PAR-99-101 BUTT, TAUSEEF R. LIFESENSORS, INC. LIVESENSORS FOR MOLECULAR PROFILING IN PROSTATE CANCER Complete
2002 R43 PAR-01-105 STRAUME, TORE GENMETRIX, LLC ASSAY FOR DETECTION OF CANCER CHROMOSOME ABNORMALITIES Complete
1999 R43 PAR-98-066 TS'O, PAUL O. P. CCC DIAGNOSTICS, LLC ISOLATION AND PROFILING OF CIRCULATING PC CELLS IN BLOOD Complete
2001 R43 PAR-99-101 JOHNSON, PAUL H EPIGENX PHARMACEUTICALS WHOLE GENOME METHYLATION ASSAY Complete
2004 R43 PAR-01-105 PARIS, MARK J VACCINEX, INC. FUNCTIONAL IDENTIFICATION OF CANCER REGULATORS Complete
2000 R43 PAR-98-066 BAMDAD, CYNTHIA C. MINERVA BIOTECHNOLOGIES CORPORATION RAPID ELECTRONIC DETECTION OF CELL SURFACE PROTEINS Complete
2002 R43 PAR-01-105 LOGE, GARY SPECTRUMEDIX CORPORATION AN AUTOMATED 2D-CAPILLARY ELECTROPHORESIS SYSTEM Complete
1999 R43 PAR-98-066 OLINER, JONATHAN D AFFYMETRIX, INC. REVERSE-ENGINEERING SIGNAL TRANSDUCTION NETWORKS Complete
2001 R43 PAR-99-101 WILLETT, CATHERINE E PHYLONIX PHARMACEUTICALS, INC. ASSAY FOR IDENTIFYING ANGIOGENIC DRUG TARGETS Complete
2004 R43 PAR-01-105 VYKOUKAL, JODY V ADEPTAS, INC. RARE CELL ISOLATION FOR MORPHOLOGICAL & MOLECULAR STUDY Complete
2003 R43 PAR-01-105 SHEN, LI SUPERARRAY BIOSCIENCE CORPORATION ID-TAG PROTEIN PROFILING ARRAY FOR THE MOLECULAR CHARACT Complete
2000 R43 PAR-98-066 PERLIN, MARK W CYBERGENETICS CORPORATION AUTOMATED MULTIPLEX GENETIC ANALYSIS TECHNOLOGY Complete
2002 R43 PAR-01-105 GAU, VINCENT JEN-JR GENEFLUIDICS, INC. RAPID MOLECULAR DETECTION OF PML/RARALPHA Complete
1999 R43 PAR-98-066 XANTHOPOULOS, KLEANTHIS G AURORA BIOSCIENCES CORPORATION ID OF NOVEL BREAST CANCER AGENTS BY FUNCTIONAL GENOMICS Complete
2001 R43 PAR-98-066 PERLIN, MARK W CYBERGENETICS CORPORATION AUTOMATED MULTIPLEX GENETIC ANALYSIS TECHNOLOGY Complete
2004 R43 PAR-01-105 HEILIG, JOSEPH S SOMALOGIC, INC. APTAMER DEVELOPMENT FOR CANCER DIAGNOSIS AND MANAGEMENT Complete
2003 R43 PAR-01-105 DIATCHENKO, LUDA ATTAGENE, INC. PROFILING OF SIGNAL TRANSDUCTION PATHWAYS IN CANCER Complete
2009 R43 RFA-CA-08-011 ZWICK, MICHAEL G ANDROBIOSYS, INC. PRIMARY XENOGRAFTS OF HUMAN TISSUE AS SURROGATES OF CANCER IN SITU Complete

Pages